Skip to main content

Table 5 PBC and PSC Study population response to treatment UDCA

From: Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center

 

PBC (n = 37)

PSC (n = 20)

Non-response

5 (8.1%)

12 (60.0%)

Response

32 (91.9%)

8 (40.0%)

  1. PBC: primary biliary cholangitis; PSC: primary sclerosing cholangitis
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us